questions for agm, page-45

Just read AGM announcement.

My concerns are:

1. HIV trial results pushed out to 1Q 2013
2. Bit225 is at least 18 months away before being able to conduct a joint trial with other DAA's for HCV.

My reasoning for comment 2 is it stated that before any partners would consider a joint trial, a 3 month human trial of bit225 for hCV would need to occur.

So, we are expecting animal toxicity trial of bit 225 to conclude 1H 2013. If Ok, then a 3 month phase 2b trial of bit225 for HCV would need to conclude. You would have to allow 9 to 12 months based on previous trials.

So, realistically, our best case scenario if all went to plan, would be around June 2014.

Now, what do you think the landscape will be at that time.